3185 results for «600058»
3185 results
Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY
18 May 2021 – From EuroPCR 2021
Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...
Transcatheter Valve Implantation or Replacement - Rescue needed: what are the options?
14 Apr 2021 – From EuroPCR 2021
If you wish to learn how to overcome challenges of mitral disease and previous atrial septum closure, how valve re-tensioning can solve hemolysis after TMVI, or how a partially anchored cardioband can detach secondary to system torsion, go and watch this session!
Percutaneous treatment of tricuspid regurgitation in 2021 - part 1
28 Apr 2021 – From EuroPCR 2021
This session will enable you to find out more about refractory heart failure in severe stand-alone tricuspid regurgitation, to study the one-shot transcatheter solution for torrential tricuspid regurgitation, and to witness full percutaneous three in one.
Coronary dissection - Part 1
28 Apr 2021 – From EuroPCR 2021
This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!
Coronary dissection - Part 2
28 Apr 2021 – From EuroPCR 2021
Don't miss this session about iatrogenic dissection of aorta in a recanalization of a chronic total occlusion, LM dissection during PCI by decompression of false lumen, complication in a morbidly obese patient with STEMI, and more!
Thrombus horribilis
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, thrombosis will no longer hold any secrets for you: observe intraprocedural acute stent thrombosis, get prepared in case of accelerated thrombosis during primary PCI, analyze the role of aggregometry in sub-acute stent thrombosis, and more!
Complex PCI in complex patients
28 Apr 2021 – From EuroPCR 2021
Watch this session to learn more about various existing ways to treat the culprit vessel during TAVI, double CTO on ECMO following in-hospital cardiac arrest, acute ST-elevation myocardial infarction and heavily calcified lesion, STEMI and cardiogenic shock, and more!
When vascular conduits deserve to be closed
28 Apr 2021 – From EuroPCR 2021
Watch these videos to learn how to use a covered stent to close a RCA fistula draining into the coronary sinus, to appraise the challenge of complex coronary fistula closure, to examine congenital coronary anomaly in an asymptomatic old patient, and more!
LM PCI in complex scenarios
28 Apr 2021 – From EuroPCR 2021
Thanks to this session, study how to handle a dangerous compression, see how to manage cardiogenic shock secondary to a left main trifurcation lesion, discover a hybrid intravascular imaging strategy for left main bifurcation PCI, and much more!
Patient-tailored treatment for bicuspid valve
14 Feb 2026 – From PCR Tokyo Valves 2026
Delve into patient-tailored treatment strategies for bicuspid aortic valve stenosis, focusing on evidence-based valve selection and sizing for TAVI candidates. This session reviews current device options, procedural planning considerations, and case studies illustrating the use of balloon-expanding and self-expanding valves, emphasizing challenges posed by unfavourable bicuspid...
Mitral TEER masterclass
14 Feb 2026 – From PCR Tokyo Valves 2026
Delve into the mitral TEER masterclass focusing on unique anatomical challenges encountered in Asian populations. This session presents complex case studies illustrating device strategies and practical techniques aimed at minimizing complications and optimizing procedural outcomes in anatomically challenging scenarios.
All you need to know about redo TAVI
15 Feb 2026 – From PCR Tokyo Valves 2026
This comprehensive session on redo Transcatheter Aortic Valve Implantation (TAVI) covers critical aspects beyond coronary obstruction risk, including detailed pre-procedural analysis, valve sizing, and innovative procedural techniques such as leaflet modification and optimal angle placement. Post-procedural considerations like antithrombotic therapy and patient-prosthesis mismatch are also thoroughly...
Miscellaneous complications: my worst nightmare
15 Feb 2026 – From PCR Tokyo Valves 2026
Explore the prevention and management of complications arising from transcatheter interventions in structural heart disease through challenging case analyses. This session presents real-world scenarios addressing complications encountered during TAVI, mitral, and tricuspid procedures, highlighting strategies to anticipate and manage these critical events effectively.
Procedural imaging for tricuspid valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
Dedicated to procedural imaging for tricuspid valve interventions, this session elucidates anatomical and pathophysiological features critical for successful transcatheter procedures. It emphasizes technical aspects of TEE and ICE imaging, including 3D multiplanar reconstruction, and offers case-based learning to refine imaging skills and optimize procedural outcomes.
Introducing the next era of coronary intravascular lithotripsy: an aero-volution in calcium modification
27 Feb 2026 – From Euro4C Annual Meeting
Explore the next era of coronary intravascular lithotripsy featuring innovative technology for calcium modification. This session covers the unique mechanism of action, practical application in complex cases, and recent clinical evidence supporting its safety and efficacy.
Novel Hertz Contact intravascular lithotripsy: calcium fragmentation with zero trade-offs
27 Feb 2026 – From Euro4C Annual Meeting
This session introduces the novel Hertz Contact intravascular lithotripsy system, designed for effective calcium fragmentation without trade-offs. It covers lesion types amenable to treatment, system mechanism, optimization tips, and discusses real-world cases along with supporting clinical trial evidence.
Mitral and aortic transcatheter valve-in-valve intervention - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...
PCR Tokyo Valves 2026 Welcome Ceremony
14 Feb 2026 – From PCR Tokyo Valves 2026
The Welcome Ceremony marks the commencement of the conference, setting the stage for an engaging and informative program dedicated to advances in cardiology and interventional techniques. It provides attendees with an overview of the event's objectives and highlights the collaborative spirit of the cardiology community.
Late-breaking trials of PCR Tokyo Valves 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents pivotal late-breaking trials from PCR Tokyo Valves 2026, offering one-year outcomes and real-world experiences in transcatheter valve therapies. Highlights include the AltaValve early feasibility study on atrial fixation TMVR, invasive registry insights on prosthesis-patient mismatch post-TAVR, and registry data on tricuspid and mitral...
TEER in complex tricuspid regurgitation - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
A 79-year-old male with permanent AF, prior colorectal and prostate cancer, and a Mosaic bioprosthetic mitral valve implanted in 2016, presented with torrential tricuspid regurgitation and preserved LV function.
Three G5 clips were implanted: two anteroseptal (1 XTW and 1 XT) and one posteroseptal XTW.
LIVE Educational Case...
